Annual report pursuant to Section 13 and 15(d)

Subsequent Events - Additional Information (Detail)

v3.23.3
Subsequent Events - Additional Information (Detail)
Aug. 11, 2023
USD ($)
$ / shares
shares
Jul. 26, 2023
Sep. 15, 2022
$ / shares
shares
Oct. 01, 2023
$ / per_unit
Oct. 01, 2023
$ / per_unit
Sep. 13, 2023
USD ($)
Aug. 15, 2023
shares
Jun. 30, 2023
$ / shares
shares
Jun. 30, 2022
shares
Apr. 22, 2020
shares
Subsequent Event [Line Items]                    
Class of warrant or right, exercise price of warrants or rights | $ / shares     $ 11.22         $ 11.22    
Number of warrants or rights outstanding               2,348,039 6,300  
Common Stock [Member]                    
Subsequent Event [Line Items]                    
Warrants convertible into shares of common stock on exercise                   6,300
Subsequent Event [Member]                    
Subsequent Event [Line Items]                    
Sale of stock issue price per share | $ / shares $ 1.9299                  
Net proceeds from public offering | $ $ 28,600,000                  
Conversion Rate       1 0.64          
Stockholders' equity, reverse stock split   On July 26, 2023, the Company effected a 1-for-17 reverse stock split (the “Reverse Stock Split”) of its common stock. In accordance with the Reverse Stock Split, 17 pre-split shares of the Company’s common were automatically converted into one issued and outstanding post-split share. Proportional adjustments were also made to all outstanding stock options, pre-funded warrants, and common warrants in accordance with their respective terms. The Reverse Stock Split did not change the par value of the Company’s common stock or the authorized number of shares. No fractional shares were issued in connection with the Reverse Stock Split. All fractional shares were rounded up to the nearest whole share with respect to outstanding shares of common stock.                
Subsequent Event [Member] | Dr. Jerel Banks [Member] | Executive Chairman and Chief Executive Officer [Member]                    
Subsequent Event [Line Items]                    
Annual base salary compensation | $           $ 655,200        
Subsequent Event [Member] | Megan Boston [Member] | Executive Director [Member]                    
Subsequent Event [Line Items]                    
Annual base salary compensation | $           $ 350,784        
Subsequent Event [Member] | Common Warrants [Member]                    
Subsequent Event [Line Items]                    
Warrants convertible into shares of common stock on exercise 2,331,606           458,134      
Subsequent Event [Member] | Common Stock [Member]                    
Subsequent Event [Line Items]                    
Warrants convertible into shares of common stock on exercise 2,331,606           458,134      
Subsequent Event [Member] | Pre-funded warrants [Member]                    
Subsequent Event [Line Items]                    
Sale of stock issue price per share | $ / shares $ 1.9298                  
Sale of stock number of shares issued in the transaction 15,126,226                  
IPO [Member]                    
Subsequent Event [Line Items]                    
Sale of stock issue price per share | $ / shares $ 1.9299   10.03              
Class of warrants or rights issue price per unit | $ / shares $ 0.0001   $ 0.17              
Issue of common stock and warrant price per share 1.93%   10.20%              
Sale of stock number of shares issued in the transaction     1,037,521              
IPO [Member] | Pre-funded warrants [Member]                    
Subsequent Event [Line Items]                    
Class of warrant or right, exercise price of warrants or rights | $ / shares     $ 0.0017              
Class of warrant or rights issued during period     715,978              
IPO [Member] | Series 2 Warrants [Member]                    
Subsequent Event [Line Items]                    
Number of warrants or rights outstanding     29,809,471         29,809,471    
Warrants convertible into shares of common stock on exercise     1,753,503         1,753,503    
IPO [Member] | Subsequent Event [Member]                    
Subsequent Event [Line Items]                    
Sale of stock issue price per share | $ / shares $ 0.0001                  
Warrants convertible into shares of common stock on exercise 16,002,175                  
Class of warrant or rights issued during period 16,002,175                  
Sale of stock number of shares issued in the transaction 875,949                  
IPO [Member] | Subsequent Event [Member] | Pre-funded warrants [Member]                    
Subsequent Event [Line Items]                    
Warrants convertible into shares of common stock on exercise 15,126,226                  
Class of warrant or rights issued during period 15,126,226                  
IPO [Member] | Subsequent Event [Member] | Series 2 Warrants [Member]                    
Subsequent Event [Line Items]                    
Class of warrant or right, exercise price of warrants or rights | $ / shares $ 1.9299